At a glance
ClinicalIndex Comparison RecordN/ACompleted· 185 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Allofit® IT Ceramic Bearing System in Total Hip Arthroplasty: A Multi-center, Prospective, Non-controlled Post Market Surveillance Study
In Brief
An observational study for Avascular Necrosis of Hip and 3 related conditions. Completed, enrolled 185 participants across 4 sites in 2 countries.
Detailed Summary
This is a multi-center, prospective, non-controlled post market surveillance study. The objectives of this study are to obtain survival and outcome data on the Allofit IT Shell in combination with the BIOLOX® delta Taper Liner when used in primary total hip arthroplasty.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAvascular Necrosis of Hip, Osteoarthritis, Hip, Inflammatory Arthritis, Post-Traumatic Osteoarthritis of Hip
CountriesGermany, Sweden
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2011
First PostedSep 2018
Primary CompletionApr 2023
TodayJul 2026
First PostedSep 17, 2018
Enrollment StartMay 1, 2011
Primary CompletionApr 1, 2023
TodayJul 2, 2026
Enrollment to primary: 11.9 yearsPosted 7.8 years ago